![]()
|
Report Date : |
24.07.2008 |
IDENTIFICATION
DETAILS
|
Name : |
NEISS LABS PRIVATE LIMITED |
|
|
|
|
Registered Office : |
D-64/52 - K Madhopur Sigra, Varanasi – 221 010, Uttar Pradesh |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
08.01.2001 |
|
|
|
|
Com. Reg. No.: |
20-25821 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U25233UP2001PTC025821 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
ALDN00198C |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AABCN5481C |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturer and Exporter of Pharmaceutical Formulations and
Generic Medicine. |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Delayed |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Mr. Mohit Jain, Director remained non-cooperative saying that he is
extremely busy to attend MIRA / TRUST SEAL business. The company has moderate track records of performance and financial
status. It’s payments are slow and delayed. The company can be considered for small to mediocre business dealings
at usual trade terms and conditions only. |
INFORMATION
DECLINED BY
|
Name : |
Mr. Mohit Jain |
|
Designation : |
Director |
|
Date : |
10.07.2008 |
LOCATIONS
|
Registered Office : |
D-64/52 - K Madhopur Sigra, Varanasi – 221 010, Uttar Pradesh, India |
|
E-Mail : |
|
|
|
|
|
Corporate Office : |
330/2642 Motilal Nagar – 2, Link Road, Goregaon (West), Mumbai – 400
090, Maharashtra, India |
|
Tel. No.: |
91-22-28745373 / 65146601 / 02 |
|
Mobile |
91-9321026889 |
|
Fax No.: |
91-22-28745067 |
|
E-Mail : |
|
|
|
|
|
Brach Office : |
SCO – 27, Sector – 54, Phase – 2, Mohali – 54, Chandigad, India |
|
Tel. No.: |
91-172-5097800 |
DIRECTORS
|
Name : |
Mr. Mohit Jain |
|
Designation : |
Director |
|
Address : |
D-64/52-K Madhopur Sigra, Varanasi – 221 010, Uttar Pradesh, India |
|
Date of Birth/Age : |
03.01.1978 |
|
Date of Appointment : |
08.01.2001 |
|
|
|
|
Name : |
Mr. Manish Jain |
|
Designation : |
Director |
|
Address : |
D-64/52-K Madhopur Sigra, Varanasi – 221 010, Uttar Pradesh, India |
|
Date of Birth/Age : |
18.04.1976 |
|
Date of Appointment : |
08.01.2001 |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
(As on 30.09.2005)
|
Names of Shareholders |
No. of Shares |
|
Mohit Jain |
5000 |
|
Manish Jain |
5000 |
|
Total |
10000 |
Equity shares Breakup (percentage of total equity)
(As on 30.09.2007)
|
Category |
Percentage |
|
Directors or relative of directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Exporter of Pharmaceutical Formulations
and Generic Medicine. |
|
|
|
|
Products : |
·
Tablets and Capsules Section ·
Liquid Medicines ·
Injectables ·
Eye and Ear Drops ·
Ointment Section ·
Ayurvedic Section ·
Anti Cancer Section ·
Speciality Medicines |
GENERAL
INFORMATION
|
Bankers : |
v
Punjab
National Bank Varanasi v HSBC Bank |
|
|
|
|
Banking Relations
: |
Unknown |
|
|
|
|
Auditors : |
|
|
Name : |
S. Ahuja and Associates Chartered Accountants |
|
Address : |
2nd Floor, Urvashi Complex, Gandhi Nagar Sigra, Varanasi –
221 010, Uttar Pradesh, India |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
40000 |
Equity Shares |
Rs. 10/- each |
Rs. 0.400 million |
|
60000 |
Preference Shares |
Rs. 10/- each |
Rs. 0.600 million |
|
|
Total |
|
Rs. 1.000
million |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
10000 |
Equity Shares |
Rs. 10/- each |
Rs. 0.100
million |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
0.100 |
0.100 |
0.100 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
0.000 |
0.000 |
0.000 |
|
|
4] (Accumulated Losses) |
(0.121) |
(0.489) |
(0.531) |
|
|
NETWORTH |
(0.021) |
(0.389) |
(0.431) |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.307 |
0.493 |
0.952 |
|
|
2] Unsecured Loans |
2.752 |
1.254 |
1.400 |
|
|
TOTAL BORROWING |
3.059 |
1.747 |
2.352 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
3.038 |
1.358 |
1.921 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
0.619 |
0.337 |
0.196 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.004 |
0.004 |
0.004 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
1.268
|
0.691 |
0.849 |
|
|
Sundry Debtors |
1.474
|
1.003 |
1.602 |
|
|
Cash & Bank Balances |
0.717
|
0.091 |
0.045 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
0.762
|
0.312 |
0.204 |
|
Total
Current Assets |
4.221
|
2.097 |
2.700 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
1.838
|
1.116 |
1.019 |
|
|
Provisions |
0.000
|
0.00 |
0.000 |
|
Total
Current Liabilities |
1.838
|
1.116 |
1.019 |
|
|
Net Current Assets |
2.383
|
0.981 |
1.681 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.032 |
0.036 |
0.040 |
|
|
|
|
|
|
|
|
TOTAL |
3.038 |
1.358 |
1.921 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
|
Sales Turnover |
|
NA |
NA |
|
Total Income |
|
NA |
NA |
|
|
|
|
|
|
Profit/(Loss) Before Tax |
|
0.383 |
0.041 |
|
Provision for Taxation |
|
0.000 |
0.000 |
|
Profit/(Loss) After Tax |
|
0.383 |
0.041 |
|
|
|
|
|
|
Total Expenditure |
|
NA |
NA |
KEY RATIOS
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
Debt Equity Ratio (Total Liability/Networth) |
|
(87.52)
|
(2.87) |
(2.36) |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.30
|
1.88 |
2.65 |
LOCAL AGENCY
FURTHER INFORMATION
Form 8
|
Name of the company |
M/s NEISS LABS
PRIVATE LIMITED |
|
Presented By |
Mr. Mohit Jain
(Director) |
|
1) Date and description of instrument creating the change |
CC Hypothecation
of Stocks Agreement dated 02.09.2002. |
|
2) Amount secured by the charge/amount owing on the securities of charge |
Rs.0.500 million |
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
Hypothecation of
Stocks of Medicines |
|
4) Gist of the terms and conditions and extent and operation of the charge. |
Margin money 25%
and other terms and conditions as per bank norms. |
|
5) Name and Address and description of the person entitled to the charge. |
Punjab National
Bank Varanasi |
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l Anti-Money
Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 41.96 |
|
UK Pound |
1 |
Rs. 83.78 |
|
Euro |
1 |
Rs. 65.82 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
3 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILIRY |
1~10 |
- |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
3 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
26 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|